[GURU] Global X Funds

Overview

Type of security: Fund

Tags: Blend, Equity, ETF, Guru Investing, Index Based, Large-cap, Not Inversed, Stocks, Unleveraged, Value/Growth

The data is delayed by 15 minutes.

 

Price: 24.38 Change: 0.1 (0.41%)
Ext. hours: Change: 0 (0%)

chart GURU

Refresh chart

Strongest Trends Summary For GURU

GURU is in the long-term up 25% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Guru Holdings Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is comprised of the top U.S. listed equity positions reported on Form 13F by a select group of entities that Solactive AG (the "Index Provider") characterizes as hedge funds. The fund is non-diversified.

See how to gain 20% in 14 sec with TrendsInvesting

Technical Data
High 52 week32.92 Low 52 week27.9 Last close27.9 Last change-1.73%
RSI23.2 Average true range0.57 Beta1.04 Volume13.22 K
Simple moving average 20 days-5.86% Simple moving average 50 days-7.24% Simple moving average 200 days-10.27%
Performance Data
Performance Week-5.99% Performance Month-8.37% Performance Quart-14.26% Performance Half-13.7%
Performance Year-5.3% Performance Year-to-date-6.06% Volatility daily1.41% Volatility weekly3.15%
Volatility monthly6.46% Volatility yearly22.37% Relative Volume132.49% Average Volume4.85 K
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio Index dividend yield Median market cap Number of holdings54
Price to Book Value Price to Earnings Total expense ratio0.75% Total net assets
Weighted market capitalization

Info

Characteristics:
NAME VALUE
Total Expense Ratio0,75
Number Of Holdings54
Top Holdings:
NAME VALUE
Burlington Stores, Inc.2,62
Ypf Sa2,19
Sprint Corp.2,13
Delta Air Lines, Inc.2,11
Nationstar Mortgage Holdings Inc.2,07
Microsoft Corporation2,05
Lear Corporation2,01
Howard Hughes Corporation1,99
Celanese Corporation1,99
Delphi Automotive Plc1,97
Other78,87
Sector Breakdown:
NAME VALUE
Information Technology21,98
Consumer Discretionary18,86
Financials17,67
Industrials11,47
Health Care10,27
Energy9,82
Telecommunication Services3,97
Consumer Staples3,92
Materials2,03

News

2019-01-09 13:00:06 | Stocks & ETFs to Pick From Goldman Sachs' Favored List in 2019

2019-01-09 08:00:01 | Hedge Funds Top Markets in 2018: ETFs in Focus

2019-01-07 10:05:03 | Winning ETF Strategies for 2019

2018-09-19 17:50:02 | Celanese’s Short Interest at Highest Level in 2018: What That Means

2018-05-31 09:44:44 | 7 Stocks the Great Investors Have Bet Big On

2017-11-13 17:46:00 | Seth Klarman's Baupost Group Bets on Beaten-Up Health Care

2017-07-07 10:09:02 | How to Build a Winning ETF Portfolio for Second-Half 2017

2017-06-02 10:05:02 | Guru ETF GURU Hits New 52-Week High

2017-05-30 09:30:01 | The Zacks Analyst Blog Highlights: Global X Guru Index ETF, AlphaClone Alternative Alpha ETF, Goldman Sachs Hedge Industry VIP ETF and Direxion iBillionaire Index ETF

2017-05-26 10:47:02 | Beat the Market with These Guru ETFs

2017-05-09 08:18:13 | Hedge Fund ETFs For A Lower Fee Than Actual Hedge Funds

2017-04-06 10:57:02 | 5 Unbeatable ETF Strategies for Q2

2017-03-24 07:35:43 | Valeant Pharmaceuticals is Developing its Sales Force

2017-03-23 07:36:15 | Valeant’s Dermatology Business Felt Pricing Pressure in 2016

2017-03-22 09:06:45 | Xifaxan Expected to Witness Robust Growth in 2017

2017-03-21 10:37:54 | Valeant’s Net Profit Margins Expected to Narrow in 2017

2017-02-17 11:52:04 | Follow Warren Buffet With These ETF Strategies

2017-02-17 11:52:04 | Follow Warren Buffett With These ETF Strategies

2017-01-26 09:30:02 | How to Beat Hedge Funds with ETFs

2016-12-27 18:05:35 | International Segment: Key Driver of VRX’s Revenue Growth in 2016

2016-12-19 13:05:28 | Factors behind Horizon Pharma’s Volatility in December

2016-11-03 15:04:13 | What Might Have Fueled Valeant’s Interest in Salix?

2016-11-03 08:00:01 | New Goldman ETF tracks popular hedge fund stock bets

2016-10-20 15:59:13 | As hedge funds suffer, so do their imitators

2016-08-27 00:01:00 | [$$] M1 Blends Automatic Saving With Robo Advisory

2016-07-13 08:36:00 | Investors Grab The Cash

2016-06-30 12:16:02 | Thursday links: nurturing untapped potential

2016-06-03 09:48:54 | Once Again, You're Better Off Letting A Monkey Pick Your Portfolio Than Investing In A Hedge Fund In 2016

2016-05-19 12:01:41 | Hedge Funds Love This 'Boring' Sector

2016-04-21 03:21:00 | Hedge Fund ETFs Just As Bad As Hedge Funds

2016-04-06 02:05:05 | Understanding Analyst Expectations for Horizon

2016-04-01 03:36:00 | IBLN: Overview of Drexion iBillionaire ETF

2016-03-16 15:11:13 | How Are Analysts Rating Valeant after the Turmoil?

2016-03-16 15:10:06 | Valeant’s Preliminary 4Q15 Revenue and Earnings

2016-02-26 15:24:08 | Goldman Sachs Files for 2 New ETFs

2016-02-25 10:06:50 | Why Fund Flows to China Financial ETFs Are Dwindling

2016-02-05 13:39:00 | China's $5 Trillion in Toxic Bank Debt Is About to Collapse -- Here's How to Profit

2016-02-05 08:24:36 | Nigeria Tries To Deal With Slumping Oil, But ETF Risks Remain

2016-02-02 01:29:00 | Meb Faber’s Hedge Fund Replication 101

2016-01-11 06:10:26 | No Refuge With Nordic ETFs

2015-12-27 11:04:24 | Fund Flows to CHIX Are Still Dwindling

2015-12-22 08:07:10 | Valeant Pharmaceuticals Reduced Guidance for Fiscal 2016

2015-11-19 16:00:17 | Using ETFs to Follow the Smart Money

2015-08-03 10:50:15 | PIIGS ETFs and Greek ADS Respond to Athens Reopening Stock Exchange

2014-08-01 10:40:29 | How About an ETF That Tracks Billionaires: the iBillionaire Index ETF

2014-08-01 08:30:00 | New 'iBillionaire' ETF looks to bring Buffett and Icahn to the masses